StonvexLoading…
StonvexStonvexStonvexCore line items from BKE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2026 2026-01-31 | Q4 2025 2025-11-01 | Q3 2025 2025-08-02 | Q2 2025 2025-05-03 |
|---|---|---|---|---|
Revenue | $1.30B | $898.70M | $577.86M | $272.12M |
Operating Income | $261.44M | $160.80M | $99.89M | $43.55M |
Net Income | $209.74M | $128.90M | $80.20M | $35.19M |
EPS (Diluted) | $4.14 | $2.55 | $1.59 | $0.70 |
Total Assets | $991.28M | $1.08B | $1.03B | $977.33M |
Total Liabilities | $566.64M | $567.64M | $552.48M | $532.06M |
Cash & Equivalents | $249.46M | $316.15M | $297.81M | $268.88M |
Free Cash Flow OCF − CapEx | $205.78M | $104.36M | $65.97M | $19.57M |
Shares Outstanding | 51.16M | 51.16M | 51.16M | 51.16M |